GY:SHL Siemens Healthineers Ag

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services worldwide. The company's Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Advanced Therapies segment produces integrated products, solutions, and services for therapy departments of healthcare providers. This segment's principal products include angiography systems and mobile C-arms. The company's Diagnostics segment offers diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics, including critical and chronic care. Siemens Healthineers AG also provides customer value chain services, including consulting, design, maintenance, operational management, training, and education services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.This company has ADRs that trade in the U.S. as the symbol SMMNY.

51.00 EUR
As of 03/22/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Germany
Country of incorporation:  Germany
IPO date:  03/16/2018
Stock exchange:    Deutsche Boerse Xetra
Exchange country:   Germany
Market cap:   61,746,847,744 EUR
Current dividend yield:   1.53%
Sedol:      BD594Y4

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy